AI-powered disease surveillance platform that tracks and predicts infectious disease outbreaks using global data sources.
BlueDot is a Canadian artificial intelligence company that specializes in infectious disease surveillance and outbreak prediction. The company uses machine learning, natural language processing, and global data sources to track and predict the spread of infectious diseases. BlueDot gained prominence for being among the first to identify and warn about the COVID-19 outbreak in late 2019. The platform serves governments, healthcare organizations, and businesses with epidemiological intelligence and risk assessment.
BlueDot has received investment from 1 venture capital firm.
AI-powered disease surveillance platform that tracks and predicts infectious disease outbreaks using global data sources.
BlueDot has received investment from Creative Destruction Lab. These venture capital firms and investors provide both capital and strategic support.
BlueDot has raised $21M in total funding, with their most recent round being a Series A. The company operates in the Digital Health sector.
BlueDot was founded in 2013 and is headquartered in Toronto, Canada.
BlueDot operates in the Digital Health sector. AI-powered disease surveillance platform that tracks and predicts infectious disease outbreaks using global data sources.
